Carpal tunnel syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Linseed oil products,with the size of a pea (depending on the size of the patient, so that the area is completely covered) and 3 times a day (morning, afternoon and night), for use in
Treatment - Drugs
Placebo
Linseed oil products,with the size of a pea (depending on the size of the patient, so that the area is completely covered) and 3 times a day (morning, afternoon and night), for use in wrist palmar are
Base of moisturizing gel, with the size of a pea (depending on the size of the patient, so that the area is completely covered) and 3 times a day (morning, afternoon and night), for use in wrist palma
Sponsors
Fasa University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: nclusion criteria: pregnancy-related carpal tunnel syndrome; patients aged between 18-45 years old; electrodiagnostic criteria for mild to severe CTS; patient's written informed consent for inclusion; having at least two signs or one sign plus one symptom of: paresthesias, numbness, tingling, night pain positive Phalen test, positive Tinnel test, positive compression test. Exclusion criteria: recurrent carpal tunnel syndrome; positive history of trauma and/or fracture of wrist bones and/or surgical release of median nerve and/or direct injection into carpal tunnel of wrist; evidence of cervical radiculopathy in EMG; systemic disease including: neuropathies (rule out by nerve conduction study of ulnar nerves) and/or collagen vascular diseases such as SLE and scleroderma and RA; endocrine diseases such as hypothyroidism and DM; other disease-inducing neuropathy; situations such as renal failure and/or alcoholism and/or poor medical condition; History of recent and ongoing use of corticosteroids or analgesics that could not be discontinued; hypersensitivity to the drug or placebo; inability to completion of data gathering forms (cognitive or language disorder).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Boston Carpal Tunnel Questionnaire score. Timepoint: At the beginning of the study and after 4 weeks. Method of measurement: Boston Carpal Tunnel Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Median nerve sensory distal latency. Timepoint: At the beginning of the study and after 4 weeks. Method of measurement: Electrodiagnosis.;Median nerve wrist sensory nerve conduction velocity. Timepoint: At the beginning of the study and after 4 weeks. Method of measurement: Electrodiagnosis.;Median nerve motor distal latency. Timepoint: At the beginning of the study and after 4 weeks. Method of measurement: Electrodiagnosis.;Median nerve compound latency. Timepoint: At the beginning of the study and after 4 weeks. Method of measurement: Electrodiagnosis. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Alireza Askari
Fasa University of Medical Sciences
Outcome results
None listed